E

Elanco Animal Health
D

ELAN

9.71000
USD
-1.07
(-9.93%)
مغلق
حجم التداول
0
الربح لكل سهم
1
العائد الربحي
-
P/E
14
حجم السوق
4,820,610,909
أصول ذات صلة
ABBV
ABBV
-3.525
(-1.72%)
201.565 USD
AMGN
AMGN
4.42
(1.45%)
310.04 USD
A
AUPH
-0.16000
(-1.95%)
8.04000 USD
BIIB
BIIB
-0.630
(-0.48%)
130.690 USD
BMY
BMY
-1.750
(-2.94%)
57.830 USD
CAH
CAH
-1.540
(-1.11%)
137.130 USD
GILD
GILD
0.450
(0.40%)
112.380 USD
I
INO
-0.06500
(-3.93%)
1.59000 USD
المزيد
الأخبار المقالات

العنوان: Elanco Animal Health

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.